close

News

LATEST POSTS from News

ConserV Bioscience and eTheRNA immunotherapies to Collaborate on Development of mRNA Vaccines for Infectious Diseases

ConserV Bioscience and eTheRNA immunotherapies to Collaborate on Development of mRNA Vaccines for Infectious Diseases  ConserV Bioscience, a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases, and eTheRNA, a clinical-stage immunotherapy company focused on mRNA antigen delivery and immunostimulation using its TriMix technology,…..

VIVEbiotech expands facilities to increase innovation and manufacturing capabilities of specialist lentiviral vectors

VIVEbiotech expands facilities to increase innovation and manufacturing capabilities of specialist lentiviral vectors VIVEbiotech, a Spanish CDMO focused on the manufacture of lentiviral vectors from R&D early stages to GMP, is expanding its manufacturing capabilities with new facilities. This expansion will enable increased production capacity and the further optimization of…..

Hide-and-seek can lead to higher drug prices

Hide-and-seek can lead to higher drug prices In Switzerland and other European countries, drug prices are regulated to ensure affordable access to drugs. In the last few years, many European countries have introduced rebate schemes for drugs. In most cases, however, the rebates negotiated with the manufacturer are confidential. This…..

Ultragenyx will build a new gene therapy manufacturing facility in Bedford (MA)

Ultragenyx will build a new gene therapy manufacturing facility in Bedford Ultragenyx Pharmaceutical, a US biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases, plans to build a new large-scale gene therapy manufacturing facility in Bedford, Massachusetts.…..